Registro:

Referencias:

• Ayres, M., Ayres, M., Jr., Ayres, D.L., Santos, A.S., BioEstat 5.0 aplicac¸ ões estatís-ticas nas áreas das ciências biomédicas (2007), fifth ed. Imprensa Oficial do Estado doPará Brazil; Bergmeyer, H.U., Bowers, G.N., Jr., Horder, M., Moss, D.W., Provisional recommendations on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2. IFCC method for aspartate aminotransferase (1976) Clin. Chim. Acta, 70, pp. F19-29
• Bessey, O.A., Lowry, O.H., Brock, M.J., A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum (1946) J. Biol. Chem., 164, pp. 321-329
• Brunetti, E., Garcia, H.H., Junghanss, T., (2009), 5, pp. 1-5. , on behalf of the members of the International CE Workshop in Lima, Peru, 2011. Cystic chinococcosis: Chronic, Complex, and Still Neglected, PloS. Negl. Trop. Dis; Ceballos, L., Elissondo, M.C., Sanchez Bruni, S., Denegri, G., Lanusse, C., Alvarez, L., Combined flubendazole-nitazoxanide treatment of cystic echinococcosis: pharmacokinetic and efficacy assessment in mice (2015) Acta Trop., 148, pp. 89-96
• Chabner, B.A., Longo, D.L., Cancer Chemotherapy and Biotherapy (2001), 3rd ed. Lippincott Williams & Wilkins Philadelphia Pennsylvania; Cucher, M., Prada, L., Mourglia-Ettlin, G., Dematteis, S., Camicia, F., Asurmendi, S., Rosenzvit, M., Identification of Echinococcus granulosus microRNAs and their expression in different life cycle stages and parasite genotypes (2011) Int. J. Parasitol., 41 (3), pp. 439-448
• El-On, J., Benzimidazole treatment of cystic echinococcosis (2003) Acta Trop., 85, pp. 243-252
• Elissondo, M.C., Dopchiz, M., Ceballos, L., Alvarez, L., Sánchez Bruni, S., Lanusse, C., Denegri, G., In vitro effects of flubendazole on Echinococcus granulosus protoscoleces (2006) Parasitol. Res., 98, pp. 317-323
• Elissondo, M.C., Ceballos, L., Dopchiz, M., Andresiuk, V., Alvarez, L., Sánchez Bruni, S., Lanusse, C., Denegri, G., In vitro and in vivo effects of flubendazole on Echinococcus granulosus metacestodes (2007) Parasitol. Res., 100, pp. 1003-1009
• Fabbri, J., Maggiore, M.A., Pensel, P.E., Denegri, G.M., Gende, L.B., Elissondo, M.C., In vitro and in vivo efficacy of carvacrol against Echinococcus granulosus (2016) Acta Trop., 164, pp. 272-279
• Ferreira, L.G., Andricopulo, A.D., Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective (2016) Drug Discov. Today, 21 (10), pp. 1699-1710
• Grem, J.L., 5-Fluorouracil: forty-plus and still ticking: a review of its preclinical and clinical development (2000) Invest. New Drugs, 18 (4), pp. 299-313
• Harasym, T., Liboiron, B., Mayer, L., Drug ratio dependent antagonism: a new category of multidrug resistance and strategies for its circumvention (2010) Methods Mol. Biol., 596, pp. 291-323
• Hares, J.I., Neijzen, R.W., Anantha, M., Dos Santos, N., Harasym, N., Webb, M.S., Allen, T., Waterhouse, D.N., Treatment of colorectal cancer using a combination of liposomal irinotecan (Irinophore C™) and 5-fluorouracil (2013) PLoS One, 8 (4), p. e62349
• Hemphill, A., Müller, J., Alveolar and cystic echinococcosis: towards novel chemotherapeutical treatment options (2009) J. Helminthol., 83, pp. 99-111
• Hennessy, D., Modifying the formulation or delivery mecanism to increase the activity of anthelmintic compounds (1997) Vet. Parasitol., 72, pp. 367-390
• Huang, Y., Wei, Y., Yang, H., Pi, C., Liu, H., Ye, Y., Zhao, L., A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing mice (2016) Drug Des. Dev. Ther., 10, pp. 997-1008
• Klinkert, M.Q., Heussler, V., The use of anticancer drugs in antiparasitic chemotherapy (2006) Mini Rev. Med. Chem., 6, pp. 131-143
• Lacey, E., Mode of action of benzimidazoles (1990) Parasitol. Today, 6, pp. 112-115
• Lanusse, C., Prichard, R., Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics (1993) Vet. Parasitol., 49, pp. 123-158
• Lanusse, C., Lifschitz, A., Alvarez, L., Basic and clinical pharmacology contribution to extend anthelmintic molecules lifespan (2015) Vet. Parasitol., 212, pp. 35-46
• Longley, D.B., Harkin, D.P., Johnston, P.G., 5-Fluorouracil: mechanisms of action and clinical strategies (2003) Nat. Rev. Cancer, 3, pp. 330-338
• McManus, D.P., Gray, D.J., Zhan, W., Yang, Y., Diagnosis, treatment, and management of echinococcosis (2012) BMJ, 344, pp. 39-44
• Moreno, M., Urrea-París, M., Casado, N., Rodríguez-Caabeiro, F., Praziquantel and albendazole in the combined treatment of experimental hydatid disease (2001) Parasitol. Res., 87, pp. 235-238
• Moreno, M., Casado, N., Urrea-París, M., Rodriguez-Caabeiro, F., Could ivermectin have a synergic effect with albendazole in hydatidosis therapy? (2002) Parasitol. Res., 88, pp. 563-567
• Moro, P., Schantz, P.M., Echinococcosis: a review (2009) Int. J. Infect. Dis., 13, pp. 125-133
• Naguib, F.N., Soong, S., el Kouni, M.H., Circadian rhythm of orotate phosphoribosyltransferase, pyrimidine nucleoside phosphorylases and dihydrouracil dehydrogenase in mouse liver: possible relevance to chemotherapy with 5- fluoropyrimidines (1993) Biochem. Pharmacol., 45, pp. 667-673
• Naguleswaran, A., Spicher, M., Vonlaufen, N., Ortega-Mora, L.M., Torgerson, P., Gottstein, B., Hemphill, A., In vitro metacestodicidal activities of genis-tein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosus (2006) Antimicrob. Agents Chemother., 50, pp. 3770-3778
• Nair, A.B., Jacob, S., A simple practice guide for dose conversion between animals and human (2016) J. Basic Clin. Pharm., 7 (2), pp. 27-31
• National Research Council US, Guide for the Care and Use of Laboratory Animals (2011), 8th edition National Academies Press (US) Washington (DC) (978-0-309-15400-0 0-309-15400-6); Nicolao, M.C., Elissondo, M.C., Denegri, G.M., Goya, A.B., Cumino, A.C., In vitro and in vivo effects of tamoxifen against larval stage Echinococcus granulosus. Antimicrob (2014) Agents Chemother., 58, pp. 5146-5154
• Nosengo, N., Can you teach old drugs new tricks? (2016) Nature, 534, pp. 314-316
• Owen, J.A., Iggo, B., Scandrett, F.J., Stewart, C.P., The determination of creatinine in plasma or serum, and in urine; a critical examination (1954) Biochem. J., 58, p. 426
• Panic, G., Duthaler, U., Speich, B., Keiser, J., Repurposing drugs for the treatment and control of helminth infections (2014) Int. J. Parasitol. Drugs Drug Resist., 4, pp. 185-200
• Pawlowski, Z., Eckert, J., Vuitton, D., Ammann, R., Kemp, P., Craig, P., Echinococcosis in humans: clinical aspects, diagnosis and treatment (2001) WHO/OIE Manual on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern, pp. 20-66. , J. Eckert M. Gemmell F. Meslin Z. Pawlowski Office International des Epizooties Paris
• Pensel, P.E., Albani, C., Ullio Gamboa, G., Benoit, J.P., Elissondo, M.C., In vitro effect of 5-fluorouracil and paclitaxel on Echinococcus granulosus larvae and cells (2014) Acta Trop., 140, pp. 1-9
• Peters, G.J., van Dijk, J., Nadal, J.C., van Groeningen, C.L., Lankelma, J., Pinedo, H.M., Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer (1986) In vivo (Athens Greece), 1, pp. 113-117
• Reuter, S., Beisler, T., Kern, P., Combined albendazole and amphotericin B against Echinococcus multilocularis in vitro (2010) Acta Trop., 115, pp. 270-274
• Shaw, L.M., Stromme, J.H., London, J.L., Theodosen, L., IFCC methods for the measurement of catalytic concentration of enzymes. Part 4. IFCC method for gamma-glutamyltransferase [(gamma-glutamyl)-peptide: amino acid gamma-glutamyltransferase, EC 2. 3. 2. 2] (1983) J Clin. Chem. Biochem., 21, pp. 633-646
• Spicher, M., Naguleswaran, A., Ortega-Mora, L.M., Müller, J., Gottstein, B., Hemphill, A., In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes (2008) Exp. Parasitol., 119, pp. 475-482
• Spicher, M., Roethlisberger, C., Lany, C., Stadelmann, B., Keiser, J., Ortega-Mora, L.M., Gottstein, B., Hemphill, A., In vitro and in vivo treatments of Echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives (2008) Antimicrob. Agents Chemother., 52, pp. 3447-3450
• Stamatakos, M., Sargedi, C., Stefanaki, C., Safioleas, C., Matthaiopoulou, I., Safioleas, M., Anthelminthic treatment: an adjuvant therapeutic strategy against Echinococcus granulosus (2009) Parasitol. Int., 58, pp. 115-120
• Stojkovic, M., Zwahlen, M., Teggi, A., Vutova, K., Cretu, C.M., Virdone, R., Nicolaidou, P., Junghanss, Treatment response of cystic echinococcosis to benzimidazoles: a systematic review (2009) PLoS Negl. Trop. Dis., 3 (9), p. e524
• Szasz, G., A kinetic photometric method for sérum ɤ-glutamyl transpeptidase (1969) Clin. Chem., 15 (2), pp. 124-136
• Talke, H., Schubert, G.E., Enzymatische hanstoff-bestimmung in blut and serum in optischen test nach Warberg (1965) Klin Wochschr., 43, pp. 174-175
• WHO Informal Working Group of Echinococcosis, Puncture, Aspiration, Injection, Re-aspiration. An Option for the Treatment of Cystic Echinococcosis (2001), pp. 1-40. , Geneva, Switzerland; Wang, W., Li, J., Yao, J., Wang, T., Li, S., Zheng, X., Duan, L., Zhang, W., In vitro and in vivo efficacies of novel carbazole aminoalcohols in the treatment of cystic echinococcosis (2017) J. Antimicrob. Chemother
• Yuan, M., Luo, Y., Xin, Q., Gao, H., Zhang, G., Jing, T., Efficacy of osthole for Echinococcus granulosus in vitro and Echinococcus multilocularis in vivo (2016) Vet. Parasitol., 226, pp. 38-43
• Zheng, H., Zhang, W., Zhang, L., Zhang, Z., Li, J., Lu, G., Zhu, Y., Wang, Y.S., The genome of the hydatid tapeworm Echinococcus granulosus (2013) Nat. Genet., 45, pp. 1168-1175
• el Kouni, M.H., Naguib, F.N., Sun, P.K., Sungman, C., Darnowskl, J., Soong, S.J., Circadian rhythm of hepatic uridine phosphorylase activity and plasma concentration of uridine in mice (1990) Biochem. Pharmacol., 40, pp. 2479-2485

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------